1-227925433-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_003395.4(WNT9A):c.182G>A(p.Arg61Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000895 in 1,597,380 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_003395.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
WNT9A | NM_003395.4 | c.182G>A | p.Arg61Gln | missense_variant | 2/4 | ENST00000272164.6 | |
WNT9A | XM_011544271.3 | c.-29G>A | 5_prime_UTR_variant | 2/4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
WNT9A | ENST00000272164.6 | c.182G>A | p.Arg61Gln | missense_variant | 2/4 | 1 | NM_003395.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000414 AC: 63AN: 152254Hom.: 0 Cov.: 35
GnomAD3 exomes AF: 0.000153 AC: 32AN: 209762Hom.: 0 AF XY: 0.000164 AC XY: 19AN XY: 115690
GnomAD4 exome AF: 0.0000554 AC: 80AN: 1445008Hom.: 0 Cov.: 32 AF XY: 0.0000654 AC XY: 47AN XY: 718130
GnomAD4 genome AF: 0.000413 AC: 63AN: 152372Hom.: 0 Cov.: 35 AF XY: 0.000335 AC XY: 25AN XY: 74516
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 22, 2021 | The c.182G>A (p.R61Q) alteration is located in exon 2 (coding exon 2) of the WNT9A gene. This alteration results from a G to A substitution at nucleotide position 182, causing the arginine (R) at amino acid position 61 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at